We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEI:NYSESolaris Energy Infrastructure, Inc. Analysis

Data as of 2026-06-01 - not real-time

$69.54

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading above its short‑term moving average while the 20‑day average sits above the 50‑day, confirming a bullish momentum. The relative strength index sits in the mid‑range, indicating room for upside without being overbought. The MACD histogram is negative and the signal line is bearish, hinting at a possible short‑term pullback. Volume trend is increasing, supporting the upward price action. The price is holding near a defined support level and well below the next resistance, outlining a clear technical corridor.
Fundamentals show revenue growth well above industry averages and solid operating margins, but earnings are pressured by a price‑to‑earnings multiple far above the sector mean and a discounted cash‑flow valuation below the market price. The balance sheet carries substantial debt relative to equity and free cash flow is negative, raising concerns about dividend sustainability despite a modest yield. Recent analyst upgrades and new long‑term contracts provide a catalyst, yet the extreme greed sentiment in the market adds speculative risk. Overall, the stock appears overvalued with a strong short‑term technical setup but significant valuation and financial headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical bullish alignment of short‑term moving averages
  • Increasing volume supporting price advance
  • Analyst target upgrades and new contract wins

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated valuation relative to peers
  • Strong revenue growth but high debt load
  • Potential earnings improvement from forward guidance

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent overvaluation and high price‑to‑earnings multiple
  • Negative free cash flow and leverage concerns
  • Uncertain dividend sustainability amid cash constraints

Key Metrics & Analysis

Financial Health

Revenue Growth55.30%
Profit Margin6.69%
P/E Ratio82.8
ROE8.74%
ROA4.98%
Debt/Equity146.47
P/B Ratio6.5
Op. Cash Flow$262.4M
Free Cash Flow$-631042496
Industry P/E20.5

Technical Analysis

TrendBullish
RSI46.1
Support$65.56
Resistance$79.21
MA 20$73.99
MA 50$67.58
MA 200$51.54
MACDBearish
VolumeIncreasing
Fear & Greed Index93.13

Valuation

Fair Value$57.62
Target Price$89.73
Upside/Downside29.04%
GradeOvervalued
TypeGrowth
Dividend Yield0.69%

Risk Assessment

Beta2.46
Volatility52.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.